We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Merck KGaA and Yissum Sign R&D Collaboration Agreement

Merck to sponsor joint program with Yissum's spin-off, QLight Nanotech, for the development of semiconductor nanoparticles technology.
News

Millipore and UMass Lowell Dedicate the Millipore Process Development Laboratory

Millipore announced the opening of the Millipore Corporation Process Development Laboratory in partnership with the university.
News

Scientist Plans $245M Research Institute on Health Care

Dietrich Stephan, founding scientist of TGen, plans to plot research institute focused on personalized medicine in a 300,000-square-foot building in Northern Virginia.
News

Tecan’s NanoQuant™ Plate Gets under the Skin of Stem Cells

Researchers at Karolinska Institute use Tecan’s Infinite® 200 microplate reader and NanoQuant Plate™ for the characterization of skin stem cells in mice.
News

Thermo Fisher Scientific Kits Used by the University of Middlesex to Detect Cancer Biomarkers

Thermo Scientific Verso cDNA Synthesis Kit and ABsolute Blue QPCR Master Mix are being used to detect expression levels of hCG beta-expressing tumor cells.
News

Genedata Strengthens TcLand Expression’s Research Informatics Infrastructure for Personalized Medicine

Genedata Phylosopher® and Expressionist® biomarker discovery platforms to be integrated into TcLand Expression’s computational infrastructure.
News

Agilent Automation Announces Presence at SBS

Company to showcase its latest automated solutions for drug discovery, target biology and stem cell therapeutics.
News

Automation Improves Tobacco Research

ATC utilizes Quantitative PCR techniques to assay transgenic plant cells, and Tecan’s Freedom EVO® 100 to automate pipetting tasks.
News

BioXell Reports Top-line OAB Phase IIb Results

Numerical improvements observed in the urodynamic trial conducted in 257 patients treated for four weeks in a multi-centre study.
News

Codon Devices Reportedly Shuts Down

The five-year-old Cambridge biotech working on ways to synthesize DNA and other genetic material is quietly shutting down.
Advertisement